Emendo Biotherapeutics develops CRISPR-based ex-vivo gene editing strategy for ELANE neutropenia Dec. 29, 2021 No Comments
Factor V/Va-targeting MAb GB-5 promotes thrombus formation in vivo for treating bleeding disorders Dec. 17, 2021 No Comments
Janssen publishes PK/PD data for the anticoagulant-reversing agent JNJ-67842125 Nov. 30, 2021 No Comments
STAR-0215, a potent and long-acting MAb plasma kallikrein inhibitor for the treatment of HAE Nov. 8, 2021 No Comments